Moinuddin Sakib M, Ibrahim Md, Sarkar Tanoy, Hossain Md Shahadat, Rose Melanie, Ahsan Fakhrul
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove, CA 95757, USA.
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove, CA 95757, USA.
STAR Protoc. 2024 Dec 20;5(4):103319. doi: 10.1016/j.xpro.2024.103319. Epub 2024 Sep 18.
Currently, there is no protocol for growing and culturing primary pulmonary arterial cells (PACs) available from the Pulmonary Hypertension Breakthrough Initiative (PHBI). Here, we present a protocol for cultivating and maintaining three major PACs collected from patients with pulmonary arterial hypertension (PAH): endothelial (PAH-ECs), smooth muscle (PAH-SMCs), and adventitial cells (PAH-ADCs). We describe steps for obtaining PACs from PHBI, evaluating the growth of cells labeled with quantum dots (QDs), and staining endothelial cell (EC) markers for immunofluorescence imaging. For complete details on the use and execution of this protocol, please refer to Al-Hilal et al..
目前,肺动脉高压突破计划(PHBI)没有提供用于培养和培育原代肺动脉细胞(PACs)的方案。在此,我们展示一种用于培养和维持从肺动脉高压(PAH)患者收集的三种主要PACs的方案:内皮细胞(PAH-ECs)、平滑肌细胞(PAH-SMCs)和外膜细胞(PAH-ADCs)。我们描述了从PHBI获取PACs、评估用量子点(QDs)标记的细胞生长情况以及对内皮细胞(EC)标志物进行染色以用于免疫荧光成像的步骤。有关此方案的使用和实施的完整详细信息,请参考Al-Hilal等人的研究。